Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients
作者： Giovanna Fattovich , Maurizio Pantalena , Irene Zagni , Giuseppe Realdi , Solko W Schalm
DOI: 10.1111/J.1572-0241.2002.07057.X
关键词: Immunology 、 Gastroenterology 、 Medicine 、 Hepatitis B 、 Internal medicine 、 HBsAg 、 Cirrhosis 、 Hepatitis 、 Hepatocellular carcinoma 、 Hepatitis C 、 Decompensation 、 Retrospective cohort study
摘要: … -related cirrhosis in terms of viremia levels and risk of hepatic … of untreated Western European patients with compensated … hepatocellular carcinoma (HCC) appearance in patients with …
nature.com
sci-hub.se 参考文章(29)
Richard Peto, M. C. Pike, Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. Biometrics. ,vol. 29, pp. 579- 584 ,(1973) , 10.2307/2529177
Felix E. De Jongh, Harry L.A. Janssen, Robert A. De Man, Wim C.J. Hop, Solko W. Schalm, Mark Van Blankenstein, Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver Gastroenterology. ,vol. 103, pp. 1630- 1635 ,(1992) , 10.1016/0016-5085(92)91188-A
A J Zuckerman, More than third of world's population has been infected with hepatitis B virus. BMJ. ,vol. 318, pp. 1213- 1213 ,(1999) , 10.1136/BMJ.318.7192.1213A
G Fattovich, L Brollo, G Giustina, F Noventa, P Pontisso, A Alberti, G Realdi, A Ruol, Natural history and prognostic factors for chronic hepatitis type B. Gut. ,vol. 32, pp. 294- 298 ,(1991) , 10.1136/GUT.32.3.294
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25
JF Tsai, JE Jeng, MS Ho, WY Chang, MY Hsieh, ZY Lin, JH Tsai, Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study British Journal of Cancer. ,vol. 76, pp. 968- 974 ,(1997) , 10.1038/BJC.1997.493
Ke-Qin Hu, Myron J. Tong, The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States. Hepatology. ,vol. 29, pp. 1311- 1316 ,(1999) , 10.1002/HEP.510290424
Lawrence Serfaty, Hugues Aumaître, Olivier Chazouillères, Anne-Marie Bonnand, Olivier Rosmorduc, Renée E. Poupon, Raoul Poupon, Determinants of outcome of compensated hepatitis C virus-related cirrhosis Hepatology. ,vol. 27, pp. 1435- 1440 ,(1998) , 10.1002/HEP.510270535
G Fattovich, G Giustina, F Degos, F Tremolada, G Diodati, P Almasio, F Nevens, A Solinas, D Mura, JT Brouwer, H Thomas, C Njapoum, C Casarin, P Bonetti, P Fuschi, J Basho, A Tocco, A Bhalla, R Galassini, F Noventa, SW Schalm, G Realdi, Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients Gastroenterology. ,vol. 112, pp. 463- 472 ,(1997) , 10.1053/GAST.1997.V112.PM9024300
Maurizia Rossana Brunetto, Filippo Oliveri, Barbara Coco, Gioacchino Leandro, Piero Colombatto, Juliana Monti Gorin, Ferruccio Bonino, Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study. Journal of Hepatology. ,vol. 36, pp. 263- 270 ,(2002) , 10.1016/S0168-8278(01)00266-5